Insiders who reported open-market trades in the last 12 months at the companies Daniel Barber files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
A. Ernest Toth Jr. - $243K in AQST purchases and sales in the last 12 months
Cassie Jung - $191K in AQST purchases and sales in the last 12 months
Lori J. Braender - $167K in AQST purchases and sales in the last 12 months
Julie Krop - $125K in AQST purchases and sales in the last 12 months
Peter E. Boyd - $124K in AQST purchases and sales in the last 12 months
Sherry Korczynski - $111K in AQST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Daniel Barber is a corporate insider, tracked as President and CEO, Director of Aquestive Therapeutics, Inc. (AQST). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Daniel Barber submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Daniel Barber been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($1.77M) across all tracked filings.
Daniel Barber is President and CEO, Director of Aquestive Therapeutics, Inc. (AQST). 11 SEC Form 4 filings on record going back to 2025, most recently on 16 September 2026. Most recent open-market trade: sold $120K of AQST on 16 September 2026. Lifetime open-market sales: $1.77M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by Daniel Barber.
InsiderAlpha's records for Daniel Barber go back to 2025: 11 primary Form 4 filings, an average of 5.5 per year. 6 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
